In vitro anti-Candida activity of certain new 3-(1H-imidazol-1-yl)propan-1-one oxime esters

Molecules. 2013 Sep 30;18(10):12208-21. doi: 10.3390/molecules181012208.

Abstract

Anti-Candida activities of certain new oximes 4a-d and their respective aromatic esters 5a-l are reported. The tested compounds 4a-d and 5a-l exhibited better anti-Candida profiles than fluconazole. Compound 5j, namely (E)-3-(1H-imidazol-1-yl)-1-phenylpropan-1-one O-4-chlorobenzoyl oxime emerged as the most active congener, with a MIC value of 0.0054 µmol/mL being more potent than both fluconazole (MIC > 1.6325 µmol/mL) and miconazole (MIC value = 0.0188 µmol/mL) as a new anti-Candida albicans agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / pharmacology
  • Candida albicans / drug effects*
  • Candida tropicalis / drug effects*
  • Esters
  • Fluconazole / pharmacology
  • Imidazoles / chemical synthesis*
  • Imidazoles / pharmacology
  • Miconazole / pharmacology
  • Microbial Sensitivity Tests
  • Oximes / chemical synthesis*
  • Oximes / pharmacology

Substances

  • Antifungal Agents
  • Esters
  • Imidazoles
  • Oximes
  • Miconazole
  • Fluconazole